A flyer for an event called "Important Considerations in Customizing Pain Management: Patient Selection and Dosing Strategies October 18th 2012". The flyer has a blue background with an illustration of a human skeleton on the left side. The skeleton is shown in a side view with the bones and muscles clearly visible. There is a red glow on the lower spine appearing to indicate lower back pain. On the right side of the flyer there is text that explains the program overview program objectives expert faculty panel and registration. The bottom of the flyer shows logos for Mallinckrodt Covidien and Exalgo.
Description 
Type
Category
Source 1 of 8
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2012
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![An infographic that explains the benefits of full therapeutic value for patients like Patrick. It has a blue background with white text and an illustration of Patrick in the center. The illustration is of a man with his arms crossed and a serious expression on his face. <br /><br />On the left side of the image there is a line graph that shows hours on the x-axis and the pain plasma hydromorphone level on the y-axis demonstrating that "Exalgo remained above 50% of C[?] for more than 90% of dosing interval" as compared to hydromorphone. <br /><br />The right side of the graphic has recommended instructions on how best to treat a patient like Patrick with Exalgo and also has important risk information for Exalgo.](https://oida-resources-images.azureedge.net/public/full/3d05d7df-6b4f-46b4-a36b-ee5f924ecb77.png)
![A screenshot of a Formulary update page on the Xartemis™ XR (oxycodone HCI and acetaminophen Extended-Release Tablets (CII)) website. It explains that "Xartemis™ Xu is available unrestricted on Tier 3 for State of Connecticut EMP (CT) Commercial Patients. No PA/step therapy requirement. Patients will have an average co-pay of [placeholder]." The page has a white green and grey background with purple menu bar at the bottom.](https://oida-resources-images.azureedge.net/public/full/2d0e21be-f2dc-4e52-a1df-81df18c3880c.jpeg)
